NIH: Office of Disease Prevention

Advancing the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Pathways to Prevention. December 9-10, 2014

Panel MembersLeft to right: Kathleen M. O’Neil, Penney Cowan, Carmen R. Green, Ronit Elk, Angela L. Rasmussen

The workshop panel is a multidisciplinary body of non-federal representatives that includes an individual representing public-centered values and concerns as well as representatives from many of the following disciplines: biostatistics, epidemiology, practicing and academic health, clinical trial research, and other fields relevant to the topic. Panel members must have no vested financial or intellectual interest in the topic under review.

Panel Chairperson

  • Carmen R. Green, M.D.
    Associate Vice President and Associate Dean for
    Health Equity and Inclusion
    Health Management and Policy
    Obstetrics and Gynecology
    Office for Health Equity and Inclusion
    University of Michigan Health System
    Ann Arbor, Michigan
  • Penney Cowan
    Founder and Executive Director
    American Chronic Pain Association
    Rocklin, California
  • Ronit Elk, Ph.D.
    Research Associate Professor
    University of South Carolina College of
    Columbia, South Carolina
  • Kathleen M. O’Neil, M.D.
    Professor of Pediatrics
    Indiana University (IU) School of Medicine
    Division of Pediatric Rheumatology
    Riley Hospital for Children at IU Health
    Indianapolis, Indiana
  • Angela L. Rasmussen, Ph.D.
    Research Assistant Professor
    Katze Laboratory
    Department of Microbiology
    University of Washington
    Seattle, Washington

Panel Biographies

Carmen R. Green, M.D.

Dr. Green is the inaugural Associate Vice President and Associate Dean for Health Equity and Inclusion at the University of Michigan and Health System, as well as a tenured Professor of Anesthesiology, Obstetrics and Gynecology, and Health Management and Policy in the Schools of Medicine and Public Health. She is also is a Faculty Associate in the Institute for Health Policy and Innovation, Institute for Social Research, Cancer Center, and Depression Center. At the University's Institute for Social Research, Dr. Green is Co-Director of the Community Liaison Core and Director of the Healthier Black Elders Center for the Michigan Center for Urban African American Aging Research. She was a Robert Wood Johnson Health Policy Fellow at the Institute of Medicine of the National Academies where she was a health policy analyst in the U.S. Senate.

Dr. Green's health services research focuses on pain management outcomes, physician decision-making, access to and quality of care, health policy and has documented disparities due to age, race, gender, and class across the lifespan. She has also identified community-based structural barriers to health and pain care, including clear disparities in access to pain medication for minorities, women, and low-income individuals with chronic and cancer pain. Dr. Green's leadership in developing and diversifying the health professional and biomedical science pipeline includes service on faculty and advisory boards for programs designed to achieve a critical mass of minorities and women in the academy.

Dr. Green has held a number of leadership positions within the University of Michigan, the region, and the nation. Nationally, she has served in leadership roles with the American Pain Society and is a member the U.S. Secretary of Health and Human Services' (HHS) Interagency Pain Research Coordinating Committee, Oversight Committee for the HHS' National Pain Strategy and Co-Chair of the Disparities Committee, the Eunice Kennedy Shriver National Institute of Child Health and Human Development Council, the National Center for Medical Rehabilitation Research Board, and the American Cancer Society's Council for Extramural Affairs.

Penney Cowan

Ms. Cowan is the founder and Chief Executive Officer of the American Chronic Pain Association (ACPA). She herself is a person with chronic pain and established the ACPA in 1980 to help others living with the condition. The ACPA provides peer support and education in pain management skills to people with pain and their families. The ACPA also works to build awareness about chronic pain among professionals, decision-makers, and the general public.

Ms. Cowan served as a Consumer Representative for the U.S. Food and Drug Administration's Center for Drug Evaluation and Research Anesthetic and Analgesic Drug Products Advisory Committee for 2012 and was appointed to the Interagency Pain Research Coordinating Committee of the National Institutes of Health from 2013 to 2015.

Ronit Elk, Ph.D.

Dr. Elk is a Research Associate Professor at the College of Nursing at the University of South Carolina. In her prior position, as a Scientific Program Director of Cancer Control and Prevention Research at the American Cancer Society, she developed national extramural research programs focusing on (1) cancer health disparities, (2) palliative care, (3) cancer prevention, and (4) enhancing quality of life in survivors and families. Dr. Elk’s program funded hundreds of researchers nationwide. Her current research focus is on end-of-life care, particularly on using community-based participatory research to develop culturally tailored palliative care interventions, in a wide range of underserved populations such as rural minority elders at end of life, and lesbian, gay, bisexual, and transgender populations with advanced cancers.

Kathleen M. O'Neil, M.D.

Dr. O'Neil is a Professor of Pediatrics at Indiana University School of Medicine and Section Chief of Pediatric Rheumatology at the James Whitcomb Riley Hospital for Children at Indiana University Health, where she also is the Fellowship Program Director in Pediatric Rheumatology. Her training included a residency in pediatrics at the Yale-New Haven Hospital and post-doctoral fellowships in immunology/allergy (with a focus on immunodeficiency diseases), and pediatric rheumatology at the Johns Hopkins University Hospital. She has focused her career on children with rheumatic and autoimmune diseases as a rheumatologist since 2000. Her research centers on the pathophysiology of systemic lupus erythematosus, particularly on hormonal effects on the expression of autoimmunity during puberty. She has experience and laboratory expertise with the antiphospholipid syndrome and has collaborated on international efforts to adapt measures of vasculitis disease activity and damage to the pediatric age group. Her clinical practice involves the evaluation of children and adolescents with a variety of painful conditions and fatigue, often to determine whether the individual has rheumatic disease or not. She also evaluates and treats children with auto-inflammatory diseases. Dr. O'Neil served on the Food and Drug Administration Arthritis Advisory Committee, which she chaired for 2 years. She has participated in the past in multicenter phase 3 trials of antirheumatic medications in children and in collaborative registries through the Pediatric Rheumatology Collaborative Study Group. She has served on the Steering Committee of the Childhood Arthritis and Rheumatology Research Alliance and is a founding member of the group.

Angela L. Rasmussen, Ph.D.

Dr. Rasmussen is a Research Assistant Professor at the University of Washington. Her interests and expertise focus on translational studies of medically relevant and emerging viruses in multiple experimental models.
Dr. Rasmussen's doctoral work focused on isolating mouse-adapted rhinovirus variants. Her post-doctoral work identified critical host molecules regulating hepatitis C virus and HIV infection both in vitro and in patients.
Dr. Rasmussen also employs systems methods to identify features of pathogenesis and identify potential drug targets for many emerging or highly pathogenic viruses, including dengue, Ebola, Lassa, Lujo, Middle East respiratory syndrome-coronavirus, and H7N9 influenza.